...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Gilead GS-5829 Perspective
4
Jul 20, 2017 12:26PM
3
Jul 21, 2017 02:54PM
3
Jul 22, 2017 04:44PM
4
Jul 23, 2017 08:55AM
1
Jul 24, 2017 10:51AM

Well that would be welcome news , We have waited a hell of a long time for any type of major deal, I would think Pfizer would be one of the parties at the table doing the dance with Zenith if the results are that stellar....  

 

Share
New Message
Please login to post a reply